Wilson Martin

General Counsel

Wilson Martin has filed 11 SEC Form 4 filings (11 transaction rows) across 1 company, with disclosures dating back to 2025. 10 of those filings fall inside the rolling window. Most recent filing: Sep 16, 2026.

On the most recent filing, Wilson Martin is listed as General Counsel at ROCKET PHARMACEUTICALS, INC. Inside the rolling window, Wilson Martin reported no open-market purchases and 8 open-market sales totaling $335K in RCKT. The largest disclosed transaction in the window is a sale of 75,364 RCKT shares on Sep 11, 2026, worth $256K.

Companies traded

Other insiders at RCKT

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$335K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
RCKTSale$256KSep 16SEC ↗
RCKTSale$2KAug 20SEC ↗
RCKTSale$12KAug 17SEC ↗
RCKTSale$2KMay 21SEC ↗
RCKTSale$12KMay 14SEC ↗
RCKTSale$5KFeb 20SEC ↗
RCKTSale$41KFeb 18SEC ↗
RCKTSale$5KNov 20SEC ↗
Showing 1–8 of 8
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Wilson Martin made?

Wilson Martin has filed 11 SEC Form 4 filings (11 transaction rows) across 1 company since 2025.

Which companies does Wilson Martin trade?

Wilson Martin has filed SEC Form 4 disclosures for 1 company, including RCKT.

When was Wilson Martin's most recent SEC Form 4 filing?

Wilson Martin's most recent SEC Form 4 filing on Tracefour is dated Sep 16, 2026.

What is Wilson Martin's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Wilson Martin is listed as General Counsel.

What is Wilson Martin's total buy and sell value in the current window?

Inside the rolling retention window, Wilson Martin bought $0 and sold $335K based on SEC Form 4 filings.

What was Wilson Martin's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 75,364 RCKT shares on 2026-09-11, worth $256K, per SEC Form 4 filings.